John L. Stebbins - Concepedia

Author

John L. Stebbins

Sanford Burnham Prebys Medical Discovery Institute

Also Known As

J Stebbins, J.L. Stebbins, John L Stebbins, John L. Stebbins, John Stebbins, John L. Stebbins

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Sanford Burnham Prebys Medical Discovery Institute Virginia Commonwealth University Cedars-Sinai Medical Center Bioscience Research Johns Hopkins Medicine

About

John L. Stebbins is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.1K
2	Natural Sciences	8	8	534
3	Biochemistry	6	6	331
4	Health Sciences	1	1	30
5	Allergy	1	1	30

John L. Stebbins

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site John L. Stebbins, Surya K. De, Thomas Machleidt, Proceedings of the National Academy of Sciences Jnk-jip Interaction SiteInsulin SignalingSignaling PathwayJnk-interacting Protein-1Cell Signaling	2008	186
Standardizing Size- and Shape-Controlled Synthesis of Monodisperse Magnetite (Fe<sub>3</sub>O<sub>4</sub>) Nanocrystals by Identifying and Exploiting Effects of Organic Impurities Liang Qiao, Zheng Fu, Ji Li, ACS Nano	2017	150
Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt Y-H Han, Xihua Cao, Bingzhen Lin, Oncogene Signal TransductionSignaling PathwayMolecular PathwayCell RegulationNatural Sciences	2006	143
Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev, Cancer Research Mt1-mmp MutantCancer BiologyTumor BiologyCancer Cell BiologyAnti-cancer Agent	2012	133
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to <i>mda</i> -7/IL-24–mediated toxicity Rupesh Dash, Belal Azab, Bridget A. Quinn, Proceedings of the National Academy of Sciences	2011	123
BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins Jun Wei, John L. Stebbins, Shinichi Kitada, Journal of Medicinal Chemistry ImmunologyCell DeathPharmacotherapyCompound 2Family Proteins	2010	115
Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells Si Wang, William J. Placzek, John L. Stebbins, Journal of Medicinal Chemistry Cancer BiologyTumor BiologyAnti-cancer AgentChemotherapeutic DrugsRadiation Oncology	2012	91
Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis Meera Shah, John L. Stebbins, Antimone Dewing, Pigment Cell & Melanoma Research Cell DeathCancer BiologyTumor BiologyOxidative StressCell Regulation	2009	91
Design, Synthesis, and Structure−Activity Relationship of Substrate Competitive, Selective, and in Vivo Active Triazole and Thiadiazole Inhibitors of the c-Jun N-Terminal Kinase Surya K. De, John L. Stebbins, Li‐Hsing Chen, Journal of Medicinal Chemistry	2009	87
The Validity, Stability, and Utility of Measuring Uric Acid in Saliva Jenna L. Riis, Crystal I. Bryce, Marla J. Matin, Biomarkers in Medicine	2018	69

Page 1